HMS-019 - Enhancing treatment compliance in dysphagic patients: The role of specialized oral drug formulations across age groups

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HMS-019
• By: PANNILUNGHI, Sara (Haleon Consumer Healthcare, Switzerland)
• Co-author(s): Dr Sara Pannilunghi (Haleon Consumer Healthcare, Nyon, Switzerland)
  Dr Andrew Harrison (Haleon Consumer Healthcare, Richmond, US)
  Dr Preeti Kachroo (Haleon Consumer Healthcare, Nyon, Switzerland)
  Dr Frederique Bariguian (Haleon Consumer Healthcare, Nyon, Switzerland)
  
• Abstract:

  Background: Dysphagia, or difficulty in swallowing, affects approximately 4% of the general population, with higher prevalence in elderly, children and adults with other primary medical conditions. Overall, 1 in 25 people will experience some form of dysphagia in their lifetime. Dysphagia significantly impacts treatment compliance and adherence..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login